The American Hospital Association, along with five other national hospital associations, is urging the U.S.

Medicare Advantage is facing challenging times.

FHIR at Scale Taskforce (FAST) gives a level of interoperability that can’t be met any other way and takes in groups such as payers that have yet to fully participate, says ONC National Coordinator Micky Tripathi.

During the first nine months of 2023, the No Surprises Act (NSA) protected Americans from more than 10 million surprise medical bills, according to a new survey by AHIP and the Blue Cross Blue Shield Association.

Digital transformation in the payer industry means moving beyond the status quo. Insurance and the ways payers interact with members, especially new members in the enrollment process, are ripe for technology upgrades, according to Gary Davis, national practice leader for Noyo, a software company that unveiled an enrollment solution last year.

CDS Hooks is a standard for web service that uses FHIR to represent the patient data, but it also has a standard to provide clinical decision support recommendations, says Dr. Howard Strasberg, vice president of medical informatics at Wolters Kluwer, who with Robert Jenders, professor of Medicine at UCLA will be speaking at HIMSS24.  

Tenet Healthcare Corporation announced yesterday that it has completed the sale of three of its hospitals in South Carolina to Novant Health for approximately $2.4 billion.  It has also entered into a definitive agreement with UCI Health for the sale of four Tenet hospitals and related operations in Orange County and Los Angeles County, California […]

While Medicare Advantage remains attractive to the healthcare industry due to strong growth,  high revenue and earnings per member, profitability is on the decline, according to a new analysis by Moody’s Investor Service.

Sickle cell disease (SCD) will be the initial focus of the Centers for Medicare and Medicaid Services Cell and Gene Therapy (CGT) Access Model, which was initially announced in February 2023. 

Artificial intelligence is on the rise in healthcare, and both in-house and third-party solutions are beginning to creep their way into the market. But the monitoring of health, and the real-world impact of these AI products, is often overlooked after deployment. Many AI products lack rigorous monitoring, posing risks to patients and operations.